Health Canada Approves New Indications for PrOmnitrope(R) (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)
September 02, 2015 16:11 ET
|
Sandoz Canada
Click here for the French version.
BOUCHERVILLE, Quebec, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc., a Novartis company, has received approval from Health Canada for a number of...
Sandoz Canada launches PrAmiodarone Syringe for the treatment of several heart rhythm disorders
August 20, 2015 16:42 ET
|
Sandoz Canada
BOUCHERVILLE, Quebec, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Version française
Sandoz Canada Inc., a Novartis company, continues to innovate with the launch of PrAmiodarone Syringe (PrAmiodarone...